Ebola: Hope rises as vaccine offers 100% protection in trial

An Ebola vaccine provided 100-percent protection in a field trial in hard-hit Guinea, researchers and officials said Friday, mooting “the beginning of the end” of the killer West African outbreak.
The world is “on the verge of an effective Ebola vaccine,” the World Health Organization (WHO) said, hailing the results from the first efficacy test of the VSV-ZEBOV vaccine among people living in a high-danger zone.
“This is an extremely promising development,” added WHO chief Margaret Chan.
“An effective vaccine will be another very important tool for both current and future Ebola outbreaks.”
About 28,000 people have been infected in Guinea, Sierra Leone and Liberia in the worst Ebola outbreak in history, according to the WHO, and more than 11,000 have died.
VSV-ZEBOV may become the first licensed vaccine against the disease for which there is also no approved treatment or cure. The trial showed that the vaccine “offers 100 percent protection against Ebola after roughly one week,” said researcher Sven Trelle from the University of Bern.





For the full story, check the Vanguard Newspaper.



































Comments

Popular posts from this blog

Agric Ministry Introduces New Measures for Fertiliser Allocation

10 World Most Eloquent People

Ipebi, the Yoruba tradition shrouded in secrecy